Apellis Pharmaceuticals, Inc. · NASDAQ:APLS
Wellington Management Group LLP reported a 9.50% stake in Apellis Pharmaceuticals, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 10, 2025
Wellington Management Group LLP reported a 9.50% stake in Apellis Pharmaceuticals, Inc., 11,833,409 shares, as a passive investor on Dec 31, 2024. Filed Feb 10, 2025 (Schedule 13G/A).
- Stake
- 9.50%
- Shares
- 11,833,409
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Wellington Management Group LLP | 9.50% | 11,833,409 |
| Wellington Group Holdings LLP | 9.50% | 11,833,409 |
| Wellington Investment Advisors Holdings LLP | 9.50% | 11,833,409 |
| Wellington Management Company LLP | 9.30% | 11,833,409 |
Source
Related
- Apellis Pharmaceuticals, Inc.
- Wellington Management Group LLP
- Apellis Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Wellington Management Group LLP · Apr 7, 2026
- Schedule 13G/A · Wellington Management Group LLP · Nov 7, 2025
- Schedule 13G/A · Wellington Management Group LLP · Aug 12, 2025
- Schedule 13G/A · Morgan Stanley · Jun 5, 2026
- Schedule 13G/A · Deep Track Capital, LP · May 15, 2026
- Schedule 13G/A · Rtw Investments, LP · May 15, 2026
- Form 4 · Dunlop A. Sinclair · May 14, 2026
- Form 4 · Chopas James George · May 14, 2026